文献速递临床免疫分子诊断质量管理与危急值

西门子SARS-CoV-2抗原化学发光免疫分析法诊断急性SARS-CoV-2感染的准确性:汇总分析

Diagnostic accuracy of Siemens SARS-CoV-2 Antigen (CoV2Ag) chemiluminescent immunoassay for diagnosing acute SARS-CoV-2 infection: a pooled analysis.
PubMed 文献 · Clin Chem Lab Med · 2023-01-12

本文对西门子SARS-CoV-2抗原(CoV2Ag)化学发光免疫分析法诊断急性SARS-CoV-2感染的准确性进行了文献综述和汇总分析。检索Scopus、PubMed和medRxiv后纳入4项研究共1310份呼吸道样本(其中612份高病毒载量),计算合并灵敏度、特异度等指标。结果显示合并AUC为0.964,灵敏度0.79,特异度0.98,高病毒载量样本灵敏度达0.95,表明该高通量免疫分析法在高病毒载量样本中表现优异,可作为筛查工具。

要点

  • 西门子CoV2Ag检测合并灵敏度0.79,特异度0.98。
  • 高病毒载量样本(Ct<29-30)灵敏度达0.95。
  • 该方法接近SARS-CoV-2抗原检测最低性能标准。

核心结论

  • 西门子CoV2Ag全自动高通量免疫分析法接近SARS-CoV-2抗原检测的最低性能标准,在高病毒载量样本中表现优异,可作为COVID-19风险评估和限制病毒传播的筛查方案。

研究设计与样本

  • 对西门子SARS-CoV-2抗原(CoV2Ag)化学发光免疫分析法诊断急性SARS-CoV-2感染的准确性进行文献综述和汇总分析。
  • 检索Scopus、PubMed和medRxiv数据库,最终纳入4项研究,共1310份呼吸道样本,其中612份为高病毒载量样本。

主要发现

  • 合并曲线下面积(AUC)为0.964(95%CI 0.957-0.971),准确度为86.9%(95%CI 84.9-88.7%)。
  • 合并灵敏度为0.79(95%CI 0.76-0.82),特异度为0.98(95%CI 0.96-0.99)。
  • 阴性预测值(NPV)为0.77(95%CI 0.74-0.79),阳性预测值(PPV)为0.98(95%CI 0.96-0.99)。
  • 高病毒载量样本(Ct<29-30)的诊断灵敏度为0.95(95%CI 0.93-0.97)。

关键数值与推荐

  • 合并AUC 0.964(95%CI 0.957-0.971),准确度86.9%(95%CI 84.9-88.7%)。
  • 合并灵敏度0.79(95%CI 0.76-0.82),特异度0.98(95%CI 0.96-0.99)。
  • NPV 0.77(95%CI 0.74-0.79),PPV 0.98(95%CI 0.96-0.99)。
  • 高病毒载量(Ct<29-30)样本灵敏度0.95(95%CI 0.93-0.97)。

临床怎么用

  • 该检测可作为COVID-19风险评估和限制病毒传播的筛查工具,尤其在高病毒载量样本中性能优异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This article provides a critical literature review and pooled analysis of diagnostic accuracy of the fully-automated Siemens SARS-CoV-2 Antigen (CoV2Ag) chemiluminescent immunoassay for diagnosis of acute SARS-CoV-2 infections. METHODS: An electronic search was conducted in Scopus, PubMed and medRxiv using the keywords ["Siemens AND CoV2Ag"] OR ["Siemens AND SARS-CoV-2 AND antigen"] for capturing studies that investigated the accuracy of Siemens CoV2Ag for diagnosing acute SARS-CoV-2 infection against a reference SARS-CoV-2 molecular test. The retrieved information was used for constructing a 2 × 2 table and for calculating pooled diagnostic sensitivity, specificity, Summary Receiver Operating Characteristic Curve (SROC) and Agreement. This study followed the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) reporting checklist. RESULTS: Four studies totalling 1,310 respiratory samples (612 with high viral load) were finally included in our analysis. The cumulative area under the curve, accuracy, sensitivity, specificity, were 0.964 (95% CI, 0.957-0.971), 86.9% (95% CI, 84.9-88.7%), 0.79 (95% CI, 0.76-0.82) and 0.98 (95% CI, 0.96-0.99), respectively. The negative (NPV) and positive (PPV) predictive values were 0.77 (0.74-0.79) and 0.98 (95% CI, 0.96-99), respectively. The diagnostic sensitivity in samples with high viral load (i.e., Ct<29-30) was 0.95 (95% CI, 0.93-0.97). CONCLUSIONS: The Siemens CoV2Ag fully-automated and high-throughput immunoassay approximates the minimum performance criteria for general SARS-CoV-2 antigen testing and displays excellent performance in samples with high viral load, thus representing a valuable screening solution for risk assessment in COVID-19 and for limiting viral spread.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Lippi G, Henry BM, Plebani M, et al. Diagnostic accuracy of Siemens SARS-CoV-2 Antigen (CoV2Ag) chemiluminescent immunoassay for diagnosing acute SARS-CoV-2 infection: a pooled analysis. Clin Chem Lab Med. 2023. PMID: 36634305. doi:10.1515/cclm-2022-1287

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。